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Abstract
Background: To identify factors affecting the harvest of lymph nodes (LNs) and to investigate the association
between examining a minimum of 12 LNs and clinical outcomes in stage I-III colorectal cancer (CRC) patients.
Methods: The clinicopathologic features and the number of examined LNs for 1167 stage I-III CRC patients were
analyzed to identify factors affecting the number of LNs harvested and the correlations between clinical outcomes
and high harvests (≧12 LNs) and low harvests (<12 LNs).
Results: A multivariate analysis showed that age (P = 0.007), tumor size (P = 0.030), and higher T stage (P = 0.001)
were independent factors affecting the examinations of LNs in colon cancer and that tumor size (P = 0.015) was the
only independent factor in rectal cancer. Patients with low harvests had poorer overall survival with stage II and
stage III CRC (stage II: P < 0.0001; III: P = 0.001) and poorer disease-free survival for stages I-III (stage I: P = 0.023; II:
P < 0.0001; III: P = 0.001).
Conclusions: The factors influencing nodal harvest are multifactorial, and an adequate number of examined LNs
(≧12) is associated with a survival benefit. Removal of at least 12 LNs will determine the lymph node status reliably.
Keywords: Lymph nodes harvested, Colorectal cancer, Disease-free survival, Overall survival, Impact of examining
lymph nodes
Background
In the 7th edition of the AJCC Cancer Staging Hand-
book published by the American Joint Committee on
Cancer (AJCC) and the International Union Against
Cancer (UICC), the recommendation for the number of
lymph nodes (LNs) that need to be removed is 10–14
[1]. As the detection of positive LNs is critical for the
prediction of patient outcomes, an adequate number of
LNs must be examined. In a commentary on TNM clas-
sification, Compton and Green indicated that at least 12
LNs need to be removed [2]. In addition, the “College of
American Pathologists Consensus Statement” [3] and
the clinical practice guidelines from the National Com-
prehensive Cancer Network [4] also recommend that at
least 12 LNs be removed.
Despite emerging data on the prognostic utility of mo-
lecular profiling, pathologic assessment of resected spec-
imens remains the strongest predictor of survival in
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patients with CRC. Goldstein et al. [5] used mathemat-
ical models to show a direct linear relationship between
LN yield and the probability of finding a positive node.
Moreover, LN harvest has been shown to impact clinical
outcomes in patients with stage II and stage III disease,
such that more negative LNs confer a survival advantage
[6–8]. In addition, Sarli et al. reported that the factors
influencing nodal harvest are multifactorial [9]. Three
key variables are thought to impact LN yield, including
patient-dependent factors, surgeon-dependent factors,
and the pathologic assessment of specimens.
Data from large series of cases from single institutions
are rare. The aims of this retrospective study were to ad-
dress this issue by identifying the factors affecting the
harvest of LNs and by examining the associations be-
tween the 12-LN measure and clinical outcomes to
analyze the impact of the pathological examination of 12
regional LNs on overall survival (OS) and disease-free




This was a retrospective single institution cohort study.
Between January 2006 and October 2013, a total of 1340
elective and consecutive patients with stage I-III CRC, as
defined by the Union for International Cancer Control
(UICC), who underwent radical resection at a single in-
stitution were considered for enrollment, with those pa-
tients who experienced surgery-related death (66
patients), who were lost to follow-up for over one year
(86 patients), or who received neoadjuvant treatment (21
patients) being excluded. Ultimately, we enrolled 1167
stage I-III CRC patients. All the enrolled patients re-
ceived detailed studies, including laboratory data ana-
lyses, colonofiberscopy, image studies (i.e., abdominal
computed tomography (CT), chest X-ray, magnetic res-
onance imaging (MRI), etc.) before surgery. All clinical
data were obtained with informed consent from each
subject, and the study protocol was approved by the Insti-
tutional Review Board of Kaohsiung Medical University
Hospital (KMUHIRB-E-20150004).
The resected specimen from each patient was fixed in
10 % formalin solution and then routinely processed for
paraffin embedding. Conventional methods of visual in-
spection and palpation were used to identify the LNs. The
histological type (adenocarcinoma or mucinous carcinoma
if > 50 % of the tumor volume was composed of mucin)
and histological grade of each tumor specimen were eval-
uated. Development of a new local recurrence (tumor
growth restricted to the anastomosis or the region of the
primary operation) or distant metastatic lesions (distant
metastases or diffuse peritoneal carcinomatosis) during
the period of postoperative surveillance was defined as a
postoperative relapse [10]. All enrolled patients were
followed up until death or December 2014.
Type of surgery
The patients made their own choices with regard to re-
ceiving open surgery or laparoscopy-assisted surgery.
According to the tumor location, we carried out which-
ever of the two surgical methods was chosen in accord-
ance with the standard procedure for the given method.
Radical (R0) resection is defined as any gross residual
tumor that did not remain in the surgical bed, and the
surgical resection margin is pathologically negative for
tumor invasion. Total mesorectal excision was performed
in all patients with tumors of the middle and lower rectum
and a distal clearance of at least 2 cm from the edge of the
tumor.
Detection of serum CEA, vascular invasion, and perineural
invasion
A 3-ml peripheral blood sample was obtained from each
of the 1167 CRC patients less than 1 week prior to the op-
eration (preoperative CEA). Serum CEA levels were also
determined by means of an enzyme immunoassay test kit
(Beckman Coulter, Inc., Fullerton, CA), with an upper
limit of 5 ng/ml being defined as normal according to the
manufacturer of the kits that were used. Vascular invasion
was identified on the basis of one or more of the follow-
ing: tumor cells lining the venous endothelial surface,
tumor cell thrombi inside the lumen of the vein, or de-
struction of the vein wall by tumor cells. Perineural inva-
sion was identified when a positive judgment was made
when cancer cells were observed extraneurally.
Definition of regional lymph nodes
Pericolic lymph nodes and nodes along the trunks of
named vessels are defined by the International Union
Against Cancer (UICC) as regional lymph nodes (ileocolic,
right colic, middle colic, superior mesenteric, left colic, in-
ferior mesenteric, and sigmoidal arteries). Metastases in
all other nonregional lymph nodes (e.g., interaortocaval,
external iliac) are regarded as distant metastases [11, 12].
Clinicopathological features and postoperative
surveillance
The clinicopathological features analyzed in this investi-
gation included the patients’ gender, age, tumor size,
tumor location, UICC stage, depth of invasion, numbers
of examined lymph nodes, vascular invasion, perineural
invasion, tumor grade, tumor histology, preoperative
carcinoembryonic antigen (CEA) level and type of sur-
gery. Adjuvant chemotherapy was administrated to pa-
tients with high-risk stage II and stage III CRC
according to the treatment guidelines of our institution.
The high-risk stage II CRC patients included those with
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colonic obstruction or perforation, T4 invasive depth,
positive vascular invasion, numbers of lymph node re-
trieval less than 12, and poorly differentiated adenocar-
cinoma. Postoperative surveillance consisted of a
medical history, physical examination, and laboratory
studies, including serum CEA levels every 3 months. Ab-
dominal ultrasonography was performed every 6 months,
and chest radiography and abdominal or chest CT scans
were performed once a year or as each patient’s clinical
condition indicated. The enrolled patients were followed
up at 3-month intervals for an initial 2 years and then at
6-month intervals thereafter till 5 years.
Disease-free survival (DFS), overall survival (OS) and TNM
stage
We estimated the correlations between disease-free sur-
vival (DFS), overall survival (OS), and the different UICC
stages according to the adequacy of the number of
lymph nodes retrieved. DFS was defined as the length of
time after primary surgery during which a patient sur-
vives with no sign of CRC. OS was defined as the time
elapsed between the primary surgery and death from any
cause.
Statistical analysis
Continuous variables are presented as mean ± standard
deviation (SD), and dichotomous variables are presented
as number and percentage values. All statistical analyses
were performed using the Statistical Package for the So-
cial Sciences, version 19.0 (SPSS, Inc., Chicago, IL). Ac-
cording to the number of LNs harvested, patients were
categorized into a high-harvest group (≧12 LNs exam-
ined) or low-harvest group (<12 LNs examined). The
clinicopathological characteristics of these two groups
were compared using either the Pearson chi-square or
ANOVA test, as appropriate. Binary logistic regression
was used to evaluate the association between the 12-
lymph node measure and clinicopathological variables
found to be significant in univariate analyses. Logistic re-
gression coefficients were used to estimate odds ratios
(OR) for each of the independent variables in the model.
Patient survival was estimated by the Kaplan-Meier
method, and the log rank test was used to determine the
difference. A P value of less than 0.05 was considered
statistically significant.
Results
Demographics of the enrolled 1167 stage I-III CRC
patients
Demographic data for the enrolled 1167 patients are
shown in Table 1. We followed the enrolled 1167 pa-
tients until December 2014, with a mean follow-up
period of 44.17 ± 26.13 months (range: 12–107 months).
We further found that 807 patients (69.2 %) were in the
high-harvest group; meanwhile, 360 patients (30.8 %)
were in the low-harvest group. Figure 1 shows the distri-
bution of the case numbers; the mean value ± SD and
median value were 15.73 ± 9.29 and 14, respectively.
Association between clinicopathologic features and the
number of examined LNs
For colon cancer patients
Based on a univariate analysis of the correlations be-
tween the examined number of LNs (high-harvest group
vs. low-harvest group) and clinicopathologic features, we
found that there were statistically significant differences
between the two groups in terms of age (P = 0.004),
tumor size (P = 0.001), depth of tumor invasion (P <
0.0001), and TNM stage (P = 0.001) (Table 2). However,
there were no significant differences in terms of gender,
Table 1 The clinicopathologic characteristics of 1167 stage I-III
colorectal cancer patients following radical resection
Variables Number (%)
Gender
Male/Female 691 (59.2)/476 (40.8)
Age (y/o)
≧65/<65 610 (52.3)/557 (47.7)
Maximum size (cm)
≧5/<5 414 (35.5)/753 (64.5)
Tumor location
Colon/Rectum 797 (68.3)/370 (31.7)
Tumor stage
I/II/III 302 (25.9)/425 (36.4)/440 (37.7)
T stage
T1/T2/T3/T4 121 (10.4)/239 (20.5)/723 (61.9)/84 (7.2)
Harvested LN Noa
≧12/<12 807 (69.2)/360 (30.8)
Vascular invasion
Yes/No 261 (22.4)/906 (77.6)
Perineural invasion
Yes/No 303 (26.0)/864 (74.0)
Tumor grade
WD/MD/PDb 96 (8.3)/969 (83.0)/102 (8.7)
Tumor histology
A/M/Sc 1097 (94.0)/66 (5.7)/4 (0.3)
Preoperative CEAd (ng/ml)
≧5/<5 441 (35.2)/756 (64.8)
Type of surgery
Open/Laparoscopic 967 (82.9)/200 (17.1)
aLN No numbers of lymph nodes
bWD well differentiated, MD moderately differentiated, PD
poorly differentiated
cA adenocarcinoma, M mucinous carcinoma, S signet-ring cell carcinoma
dCEA carcinoembryonic antigen
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tumor histology, tumor grade, vascular invasion, peri-
neural invasion, type of surgery, and preoperative CEA
level. Using a multivariate logistic regression analysis, we
found that the high-harvest group was statistically youn-
ger than the low-harvest group (P = 0.007; odds ratio
[OR], 1.582; 95 % confidence interval [CI], 1.131–2.212),
had a larger mean size of tumor (P = 0.030; OR, 1.503;
95 % CI, 1.040–2.171), and had a more advanced mean
depth of invasion (P = 0.001; OR, 1.919; 95 % CI, 1.318–
2.795).
For rectal cancer patients
Table 3 shows the correlations between clinicopathologic
features and harvested lymph nodes for 370 UICC stage
I-III rectal cancer patients. Using univariate analysis, it
was demonstrated that there were statistically significant
differences between the two groups in terms of tumor
size (P = 0.006) and TMN stage (P = 0.023). However,
there were no significant differences with regard to the
remaining variables. Furthermore, we used a multivariate
logistic regression analysis and found only that the mean
size of tumor (P = 0.015; OR, 1.855; 95 % CI, 1.127–
3.053) was significantly larger for the high-harvest group
than for the low-harvest group.
Disease-free survival and overall survival based on the
number of examined LNs
We further validated the clinical significance of the
number of examined LNs on DFS and OS in stage I-III
CRC patients. For stage I cases, the OS of CRC patients
in the low-harvest group was not significantly lower
than that of the CRC patients in the high-harvest group
(P = 0.347; Fig. 2a); however, the DFS was significantly
lower in the low-harvest group (P = 0.023; Fig. 2b). For
stage II cases, both the DFS and OS were significantly
higher in the CRC patients in the high-harvest group
(both P < 0.0001; Fig. 3). Likewise, the results also indi-
cated better outcomes for stage III CRC patients in the
high-harvest group (both P = 0.001; Fig. 4).
Discussion
The novel aspects and findings of the present study were
as follows: (1) there appeared to be only one independ-
ent factor affecting the harvest of lymph nodes for stage
I–III rectal cancer patients; (2) we found that an ad-
equate number of retrieved LNs was most significantly
associated with the DFS of stage I-III CRC patients and
the OS of stage II and III CRC patients; and (3) this is
the first comprehensive report identifying significant fac-
tors predicting the retrieval of lymph nodes in colon
cancer and rectal cancer respectively.
Previous researchers have demonstrated a relationship
between the number of histologically examined lymph
nodes and prognosis: the more LNs examined, the better
the prognosis [13–16]. Numerous observational studies
have also shown that CRC patients for whom an ad-
equate number of LNs have been examined have a con-
siderably lower rate of mortality [17, 18]. The 12 lymph
node benchmark for LN retrieval and examination arose
in recent years from the observed relationship between
higher numbers of LNs and improved patient survival
[19]. Moreover, the results of this study support previous
findings that there are many factors influencing the har-
vest of regional lymph nodes [9].
Our results are similar to the finding of previous stud-
ies that the number of LNs harvested is inversely associ-
ated with the age of colon cancer patients [20, 21].
Inflammation and its contributing process have been
Fig. 1 The distribution of examined lymph nodes from 1167 stage I-III colorectal cancer patients who underwent radical resection
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known to cause LNs to become enlarged, making them
easier to identify than normal nodes among both sur-
geons and pathologists [22]. Tekkis et al. [23] reported
that older individuals could have reduced immunologic
and inflammatory reactions to cancers that would lead
to decreased numbers of LNs being harvested. It is also
possible that LNs may undergo a process of involution
with increasing age.
One interesting finding of the current study is that lar-
ger tumors are more likely to result in a higher nodal
Table 2 Univariate analysis and logistic regression analysis
correlations between the number of harvested lymph nodes
(≧12 LNs examined in the high-harvest group or < 12 LNs exam-
ined in the low-harvest group) and other variables among 797




























































































b95 % CI 95 % confidence interval
cM mucinous carcinoma, S signet-ring cell carcinoma, A adenocarcinoma
dPD poorly differentiated, MD moderately differentiated, WD
well differentiated
eCEA carcinoembryonic antigen
Table 3 Univariate analysis and logistic regression analysis
correlations between the number of harvested lymph nodes
(≧12 LNs examined in the high-harvest group or < 12 LNs exam-
ined in the low-harvest group) and other variables among 370
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cM mucinous carcinoma, S signet-ring cell carcinoma, A adenocarcinoma
dPD poorly differentiated, MD moderately differentiated, WD
well differentiated
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harvest regardless of whether the given patient has colon
cancer or rectal cancer, a result which is consistent with
the observations of Chen et al. [24]. A biological explan-
ation for this finding is not yet known, but it is possible
that larger tumors may lead to more profound inflam-
matory responses in the mesentery basin, resulting in a
greater number of LNs (though not necessarily positive
LNs) in the resected mesentery being harvested for
pathological examination. In addition, it is noteworthy
that our data indicated that T-descriptor, which refers to
the depth of wall penetration in the colon was directly
correlated with the number of LNs retrieved. A deeper
penetration of the bowel wall found in patients with T3
or T4 tumors may result in a greater antigenic immune
and inflammatory response within the regional LNs,
making them more apparent to pathologic examination
[20]. In a population-based study of 2281 CRC patients,
Kelder et al. [25] also demonstrated that T stage was in-
dependently associated with the number of examined
LNs. In that study, the number of LNs recovered in-
creased with advanced TNM stage, and we found the
controversial results in our study.
In this study, the mean examined number of LNs was
15.73 ± 9.29. Our enrolled patients with LNs examin-
ation are adherent to the LN quality measure, of which
the 12 LNs goal is nearly 70 %. Three population-based
studies have confirmed the impact of a high number of
examined LNs (≧12) on long-term survival in patients
with stage II CRC [26, 27]. However, some reports on
stage III CRC are contradictory. Vather et al. reported
that the 5-year survival rate was increased with in-
creased nodal harvests, with the greatest difference oc-
curring at the < 12 and ≧12 LNs cut-off [27]. Conversely,
Kelder et al. reported no significant difference in survival
in three subsets of nodal harvests (<6, 6–11, and ≧12) in
738 stage III patients [25]. We found that stage I-III
CRC patients with a higher number of examined LNs
(≧12) had better overall survival rates than those with a
lower number of examined LNs (<12). In terms of DFS,
the same observations applied except for among the
stage I CRC patients. This may have been due to the
relatively low rate of recurrence for the stage I CRC pa-
tients. Herein, we propose three possible mechanisms
for the detrimental impact of low LN harvests on sur-
vival: (1) surgeon-related factors, with worse survival be-
ing associated with less complete resections, which also
lead to less nodes being removed [28]; (2) pathologist-
related factors, with worse survival occurring due to the
phenomenon of stage migration [29]; (3) a mechanism
reflecting interactions between the tumor and the host
that may also be associated with prognosis [30].
The limitations of this study were as follows: (1) it
consisted of a retrospective cohort study involving only
a single institute; (2) it involved many surgeons, and
Fig. 2 Cumulative survival rates of the 302 enrolled patients with stage I colorectal cancer (CRC) who underwent curative resection as assessed
by the Kaplan-Meier method. The differences in survival rates were analyzed by the log-rank test. a The rates of overall survival were not
significantly different between the high-harvest group (≧12 LNs examined) and the low-harvest group (<12 LNs examined) in stage I CRC
patients. b The disease-free survival was significantly lower in the low-harvest group than in the high-harvest group
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Fig. 4 Cumulative survival rates of the 440 enrolled patients with stage III colorectal cancer (CRC) who underwent curative resection as assessed
by the Kaplan-Meier method. The differences in survival rates were analyzed by the log-rank test. a The overall survival was significantly lower in
the low-harvest group (<12 LNs examined) than in the high-harvest group (≧12 LNs examined). b The disease-free survival was also considerably
lower in the low-harvest group than in the high-harvest group
Fig. 3 Cumulative survival rates of the 425 enrolled patients with stage II colorectal cancer (CRC) who underwent curative resection as assessed
by the Kaplan-Meier method. The differences in survival rates were analyzed by the log-rank test. a The overall survival was significantly lower in
the low-harvest group (<12 LNs examined) than in the high-harvest group (≧12 LNs examined). b The disease-free survival was also considerably
lower in the low-harvest group than in the high-harvest group
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surgeon-dependent factors might be among the most
important factors affecting the harvest of lymph nodes;
and (3) we did not categorize the surgeries by the ana-
tomic type of resection (e.g. right-hemicolectomy, left-
hemicolectomy, sigmoidectomy, extended, lower anter-
ior resection etc.), which may have resulted in a statis-
tical bias. More accurate identification of patients with
an adequate retrieval of lymph nodes and appropriate in-
tensive treatment/follow-up, especially systematic chemo-
therapy, may improve the efficacy of various treatments
and overall survival. However, it will be necessary to
analyze clinical data from multiple institutions in order to
develop simpler, more sensitive, and specific criteria for
detecting patients with a high prediction of sufficient
lymph-node retrieval and, in turn, to improve clinical
outcomes.
Conclusion
This study further confirmed that a total of 12 or more
examined LNs is associated with increased long-term
survival in stage I-III CRC patients. Furthermore, a
minimum of 12 LNs examined is not only the standard
of care, and thus important in predicting outcomes and
directing treatment goals, but is also associated with a
reduction in mortality.
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